Giannoudis A, Malki MI, Rudraraju B, Mohhamed H, et al. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Res 2020;22:126.
PMID: 33198803